So far, a role for Haspin in cancer formation has not been formally established17, although Haspin inhibitors such as CHR-6494 have been demonstrated to have antitumor activity in cervical cancer, breast cancer and colon cancer cell lines18. The gene discussed is HASPIN; the disease is breast carcinoma.